Chinese oncology-focused biopharma company Hygea Medical Technology has closed nearly 200 million yuan ($28 million) in its Series B round while video dating app Yidui has secured as much as $10 million from XVC.
Hygea bags $28m in Series B round
Chinese oncology-focused biopharma firm Hygea Medical Technology has secured nearly 200 million yuan ($28 million) in its Series B round funding led by Beijing Jianxing Medical Fund, according to a company statement.
The current round also saw the participation of Kunying Capital and Shuncheng Capital.
Established in 2010, Beijing-based Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology.
Hygea has partnered with 40 portfolio medical institutes in China including Beijing Cancer Hospital, Fudan University Shanghai Cancer Center, and Cancer Hospital Chinese Academy of Medical Science.
Video dating app Yidui gathers $10m in Series A+ round
Yidui, a video dating app operated by Beijing Milian Technology & Trade, has secured as much as $10 million in its Series A+ round of financing from XVC, a company statement noted.
It has closed Series A round funding from BlueRun Ventures.
Milian Technology, which launched the dating app in 2018, claims to have 10,000+ active profiles currently. By the end of 2019, Milian Technology is targeting to cross 1 billion yuan ($142 million) turnover mark.